Variables |
Total |
Metabolic syndrome no (Prevalence) |
PR |
95% CI (PR) |
p |
Ethnicity |
|
|
|
|
0.191 |
white or Asian |
88 |
23 (26.1) |
1 |
|
|
biracial or black |
478 |
96 (20.1) |
0.77 |
0.52 - 1.14 |
|
Parity |
|
|
|
|
0.020 |
not applicable (virgins) |
84 |
11 (13.1) |
1 |
|
|
without children |
393 |
80 (20.6) |
1.57 |
0.88 - 2.82 |
|
with children |
89 |
27 (30,3) |
2.32 |
1.22 - 4.37 |
|
Menstrual Irregularity and amenorrhea |
|
|
|
|
0.640 |
no |
59 |
11 (18.6) |
1 |
|
|
yes |
507 |
108 (21.3+A1:F33) |
1.14 |
0.653 - 2.00 |
|
Hirsutism |
|
|
|
|
0.029 |
no |
46 |
3 (6.5) |
1 |
|
|
yes |
520 |
116 (22.3) |
3.42 |
1.13 - 10.35 |
|
Hyperandrogenemia |
|
|
|
|
0.807 |
no |
272 |
56 (20.6) |
1 |
|
|
yes |
294 |
63 (21.4) |
1.04 |
0.76 - 1.43 |
|
Polycystic ovaries |
|
|
|
|
0.900 |
no |
126 |
27 (21.4) |
1 |
|
|
yes |
440 |
92 (20.9) |
0.98 |
0.67 - 1.43 |
|
Family history of diabetes |
|
|
|
|
0.394 |
no |
38 |
10 (26.3) |
1 |
|
|
yes |
528 |
109 (20.6) |
0.78 |
0.45 - 1.37 |
|
Family history of hypertension |
|
|
|
|
0.639 |
no |
506 |
105 (20.7) |
1 |
|
|
yes |
60 |
14 (23.3) |
1.12 |
0.69 - 1.83 |
|
Family history of gynecological cancer |
|
|
0.329 |
no |
554 |
118 (21.3) |
1 |
|
|
yes |
12 |
1 (8.3) |
0.39 |
0.06 - 2.58 |
|
Family history of nongynecological cancer |
|
|
0.704 |
no |
541 |
113 (20.9) |
1 |
|
|
yes |
25 |
6 (24.0) |
1.15 |
0.56 - 2.35 |
|
Quantitative Variables |
without Metabolic Risk |
with Metabolic Risk |
p* |
mean (SD); median (min-max) |
mean (SD); median (min-max) |
Age |
26.1 (5.8); 25.0 (14 - 39) |
27.7 (6.1); 28.0 (14 - 39) |
0.006 |
BMI (n=308) |
27.5 (6.9); 26.9 (16.8 - 59.0) |
36.1 (7.8); 34.9 (25.1 - 56.9) |
<0.001 |
Menarche |
13.0 (1.8); 13 (9 - 18) |
12.8 (1.9); 13 (9 - 18) |
0.619 |
Time period (years) of reproductive desire(years) |
1.3 (2.2); 0 (0 - 14) |
1.9 (3.2); 0 (0 - 16) |
0.195 |
Time period (years) of irregularity (n=437) |
6.3 (5.8); 5 (0 - 28) |
7.6 (6.3); 5 (0 - 24) |
0.101 |
PR: Prevalence Ratio; SD: standard Deviation